Another press release!!
Thursday October 2 9:34 AM EDT
Company Press Release
Nutraceutix Projects Production Up Markedly
REDMOND, Wash.--(BUSINESS WIRE)--Oct. 2, 1997--
Marketing Pact with Weider Further Boosts Forecast
Nutraceutix, Inc. (OTC BB:NUTX), a developer and manufacturer of health supplements, said
today that production next year should increase at least 30 percent over 1997.
``Since the company completed installation of its new assembly line in April, we've experienced an
ongoing increase in production,'' said William St. John, Nutraceutix president. ``The production
schedule will increase in October to accommodate orders from a number of national health
supplement brands and Weider Nutrition International Inc. for the manufacture of our Calcium
D-glucarate-based cancer-inhibiting product.'' Weider (NYSE:WNI) plans to begin shipping the
glucarate products in the fourth quarter, St. John said.
Nutraceutix and Weider announced in September that Weider would market two cancer-inhibiting
products from a patented formulation of the chemical compound Calcium D-glucarate owned by
Nutraceutix. While terms of the agreement were not disclosed, St. John called it a milestone in the
company's 14-year history.
``Weider is one of the country's leading marketers of nutritional supplements,'' St. John said, ``and it
has committed considerable resources to securing the rights to and selling the glucarate products.''
Dr. Thomas Slaga, a researcher at the AMC Cancer Center in Denver and a developer of Calcium
D-glucarate, said the compound might be especially beneficial to those at higher risk for certain
kinds of cancer.
``This unique formulation of Calcium glucarate provides a degree of protection against the potential
carcinogenic harm imposed by elements found in cigarettes, and for those who are at higher risk for
breast or prostate cancer,'' said Slaga, formerly the director of cancer cause and prevention at the
University of Texas M.D. Anderson Cancer Center.
Developed by researchers at various institutions including M.D. Anderson Cancer Center, Calcium
D-glucarate is a compound found naturally in certain fruits and vegetables. Nutraceutix earlier this
year acquired the world-wide marketing rights to lung, breast and prostrate cancer applications of
Calcium D-glucarate from BioChemix, an Austin, Texas-based technology transfer company whose
principals are researchers at cancer research institutions.
Nutraceutix researches, develops, manufactures and distributes health promoting natural
compounds, food ingredients and animal health products.
Except for historical information, this news release contains certain forward-looking statements that
involve risk and uncertainties that might cause actual results to differ materially from the statements
made, including the success and timing of product development, regulatory clearances, market
launches, the establishment of new corporate alliances and other risks listed from time to time in U.S.
Securities and Exchange Commission (SEC) filings. These forward-looking statements represent
management's judgments, as of the date of this release, and the company's disclaims any intent or
obligation to update these forward-looking statements.
Additional information about Nutraceutix is available on the Internet at www.wileyco.com/NUTX/ .
Contact:
William St. John, 800/548-3222
Wiley Brooks, 800/775-5577 |
